ZIGLIM PLUS 2 MG (Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg))

Ziglim Plus 2 MG is a pharmaceutical preparation designed to assist individuals in managing their blood sugar levels. This medication is intended for use alongside a balanced diet and regular physical activity to enhance glycemic control in adults diagnosed with type 2 diabetes mellitus. The formulation aids in the effective use of insulin in the body, leading to a reduction in blood sugar concentrations. It is important to follow the prescribed dosage and duration as directed by your healthcare provider. It is recommended to take this medication with food to minimize the risk of gastrointestinal upset. In cases where a dose is missed, it should be taken promptly; however, if the time for the next dose is close, the missed dose should be omitted, and the regular dosing schedule should be resumed without doubling the dose, as an overdose can result in hypoglycemia, a condition characterized by abnormally low blood sugar levels. Patients must remain vigilant about their blood glucose levels during treatment, particularly when using other antidiabetic medications, consuming alcohol, or skipping meals, as these factors may heighten the risk of low blood sugar. Common adverse effects associated with this medication may include nausea, diarrhea, abdominal discomfort, headaches, risk of bone fractures, and respiratory infections. Individuals should disclose any existing kidney, liver, or cardiovascular conditions to their healthcare provider before starting treatment. Pregnant and breastfeeding women should also seek medical advice prior to using this medication, and healthcare professionals may conduct tests to evaluate kidney function prior to initiating therapy.